Éditeur(s) : HAL CCSDNature Publishing Group Résumé : International audience Transmembrane CD95L (Fas ligand) can be cleaved to release a promigratory soluble ligand, cl-CD95L, which can contribute to chronic inflammation and cancer cell dissemination. The motility signaling pathway elicited by cl-CD95L remains poorly defined. Here, we show that in the presence of cl-CD95L, CD95 activates the Akt and RhoA signaling pathways, which together orchestrate an allosteric activation of the Na+/H+ exchanger NHE1. Pharmacologic inhibition of Akt or ROCK1 independently blocks the cl-CD95L-induced migration. Confirming these pharmacologic data, disruption of the Akt and ROCK1 phosphorylation sites on NHE1 decreases cell migration in cells exposed to cl-CD95L. Together, these findings demonstrate that NHE1 is a novel molecular actor in the CD95 signaling pathway that drives the cl-CD95L-induced cell migration through both the Akt and RhoA signaling pathways. ISSN: 2045-2322
Livres anciens
Images
Fonds Jean Bernabé
Fonds René Maran
Esclaves de Guyane
Esclavage en Martinique
Catalogue collectif des périodiques
Audio-Vidéo
Études et recherches
Etudes Caribéennes
Tramil
Or
Esclavage et résistances